A patient with asthma exacerbation is receiving high-dose nebulized bronchodilator therapy, systemic corticosteroids, and oxygen therapy. Which assessment finding should the nurse prioritize to evaluate the effectiveness of the treatment?

D) Improved peak expiratory flow rate (PEFR)

A) Decreased wheezing on auscultation

C) Decreased use of accessory muscles

D) Improved peak expiratory flow rate (PEFR)

A patient with a history of asthma presents with an exacerbation characterized by increased respiratory effort, use of accessory muscles, and diminished breath sounds. Given the clinical findings of respiratory acidosis and hypoxemia, which nursing intervention should be prioritized to address the patient's immediate respiratory needs?

A) Administer a high-dose nebulized bronchodilator therapy.

B) Increase the patient's fluid intake to thin secretions.

C) Educate the patient on peak flow meter usage to monitor asthma.

D) Encourage the patient to perform incentive spirometry exercises.

A patient with asthma is not responding adequately to initial bronchodilator therapy, and their peak expiratory flow rate remains low. Which of the following interventions should the nurse prioritize to address the patient's respiratory distress?

C) Initiate a continuous nebulization of bronchodilators.

A) Increase the frequency of nebulized bronchodilator treatments.

B) Administer a bolus of intravenous corticosteroids.

C) Initiate a continuous nebulization of bronchodilators.

D) Start non-invasive ventilation immediately.

A patient with asthma exacerbation is being monitored after starting continuous nebulization of bronchodilators and adjusted corticosteroid therapy. Her respiratory rate remains elevated, and oxygen saturation is marginally improved. Which intervention should the nurse anticipate if the patient's condition does not improve with current measures?

B) Initiate a magnesium sulfate infusion for additional bronchodilation.

A) Increase the frequency of peak expiratory flow rate (PEFR) monitoring.

B) Initiate a magnesium sulfate infusion for additional bronchodilation.

C) Switch to oral steroids for long-term management.

D) Begin chest physiotherapy to enhance secretion clearance.

A patient with a history of asthma presents with worsening respiratory distress, increased respiratory rate, and low oxygen saturation despite supplemental oxygen. Arterial blood gas results show pH 7.32, PaCO2 52 mmHg, and PaO2 58 mmHg, indicating respiratory acidosis. Which intervention should the nurse anticipate to effectively address the patient's current respiratory status?

B) Initiate non-invasive positive pressure ventilation

A) Administer a bronchodilator via nebulizer

B) Initiate non-invasive positive pressure ventilation

C) Increase the oxygen flow rate on the nasal cannula

D) Prepare for immediate intubation and mechanical ventilation

A patient with a history of asthma is experiencing worsening respiratory distress, with blood gas analysis indicating respiratory acidosis and elevated lactate levels. What is the nurse's priority intervention to address the patient's acute condition?

D) Initiate non-invasive ventilation to support breathing efforts.

A) Increase the rate of supplemental oxygen delivery.

B) Administer a bronchodilator via nebulizer.

C) Prepare for intubation and mechanical ventilation.

D) Initiate non-invasive ventilation to support breathing efforts.

A patient with a history of asthma presents with respiratory distress, elevated blood pressure, and non-invasive ventilation is initiated. Despite slight improvements, arterial blood gas analysis shows persistent respiratory acidosis and minimal changes in gas exchange. Which intervention should the nurse prioritize to address the underlying cause of the patient's deteriorating condition?

B) Educate the patient and family on medication adherence and environmental control.

A) Increase the frequency of bronchodilator treatments.

B) Educate the patient and family on medication adherence and environmental control.

C) Prepare for immediate intubation and mechanical ventilation.

D) Administer intravenous corticosteroids to reduce inflammation.

A patient with asthma exacerbation is under non-invasive ventilation with high-flow oxygen. The team notes that despite initial improvements, the arterial blood gas analysis shows persistent respiratory acidosis. Which nursing intervention is most appropriate to prioritize at this time?

B) Collaborate with the respiratory therapist to adjust the settings on the non-invasive ventilation.

A) Encourage the patient to use her rescue inhaler more frequently.

B) Collaborate with the respiratory therapist to adjust the settings on the non-invasive ventilation.

C) Educate the patient on stress-reduction techniques to manage anxiety.

D) Prepare the patient for possible intubation and mechanical ventilation.

A patient with acute respiratory distress and asthma exacerbation is not responding adequately to non-invasive ventilation and high-flow oxygen therapy as indicated by worsening blood gas results and increased respiratory effort. What is the most appropriate nursing intervention to prioritize at this time?

B) Prepare the patient for invasive mechanical ventilation

A) Increase the frequency of bronchodilator nebulization treatments

B) Prepare the patient for invasive mechanical ventilation

C) Administer a continuous infusion of a beta-agonist

D) Initiate a high-dose corticosteroid therapy immediately

A patient with a history of asthma is exhibiting signs of respiratory distress despite non-invasive ventilation and high-flow oxygen therapy. The healthcare team is considering transitioning to invasive mechanical ventilation. Which nursing intervention should be prioritized to support this transition?

A) Administer a bronchodilator via nebulizer to improve airway patency.

B) Ensure the patient is in a supine position to facilitate mechanical ventilation.

C) Initiate intravenous corticosteroids to reduce airway inflammation.

D) Explain the procedure and obtain verbal consent from the patient for intubation.

asthma - Nursing Case Study

Pathophysiology

• Primary mechanism: Airway inflammation - Asthma is characterized by chronic inflammation of the airways, which leads to swelling and increased mucus production. This inflammation is primarily driven by the activation of immune cells like eosinophils and T-helper 2 lymphocytes, resulting in airway hyperresponsiveness.

• Secondary mechanism: Bronchoconstriction - Asthma triggers, such as allergens or irritants, cause the muscles around the airways to tighten, leading to bronchoconstriction. This reduces airflow and contributes to the characteristic wheezing and difficulty breathing experienced during an asthma attack.

• Key complication: Airway remodeling - Chronic inflammation and repeated asthma exacerbations can lead to structural changes in the airways, known as airway remodeling. This can result in permanent narrowing of the airways and reduced lung function over time, complicating disease management.

Patient Profile

Demographics:

45-year-old female, elementary school teacher

History:

• Key past medical history: Diagnosed with asthma 10 years ago, history of seasonal allergies

• Current medications: Salbutamol inhaler as needed, Fluticasone inhaler daily

• Allergies: Penicillin, pollen

Current Presentation:

• Chief complaint: Increased shortness of breath and wheezing over the past week

• Key symptoms: Persistent cough, chest tightness, difficulty speaking in full sentences, mild fatigue

• Vital signs: Temperature 98.9°F, Heart rate 110 bpm, Respiratory rate 24 breaths/min, Blood pressure 140/90 mmHg, Oxygen saturation 92% on room air

Section 1

As the healthcare team conducted an initial assessment, the focus was on the patient's respiratory status and potential complications arising from her asthma exacerbation. Upon auscultation, diffuse bilateral wheezing was noted, along with diminished breath sounds at the lung bases, suggesting possible airflow obstruction. The patient's respiratory effort was visibly increased, with the use of accessory muscles, indicating moderate respiratory distress. Her peak expiratory flow rate (PEFR) was measured at 200 L/min, significantly below her personal best of 400 L/min, corroborating the reduced airflow and poor control of her asthma symptoms.

Recognizing the need for further investigation, the team ordered a chest X-ray and basic laboratory tests. The chest X-ray showed no signs of pneumonia or pneumothorax, but there were subtle indications of hyperinflation consistent with asthma. Blood work revealed an elevated eosinophil count, supporting the inflammatory nature of her current exacerbation. Arterial blood gas analysis showed a pH of 7.36, a pCO2 of 46 mmHg, and a pO2 of 70 mmHg, indicating respiratory acidosis with some degree of hypoxemia, raising concerns about her ability to maintain adequate ventilation.

Given these findings, the healthcare team decided to escalate her treatment. The patient was commenced on a high-dose nebulized bronchodilator therapy and systemic corticosteroids to address the acute inflammation and bronchoconstriction. Oxygen therapy was initiated to improve her oxygen saturation levels. The team discussed the possibility of initiating a long-term asthma management plan to prevent future exacerbations and address potential airway remodeling. They also considered the need for a referral to a pulmonologist for ongoing management and further investigation, such as spirometry, to assess the extent of airway remodeling and adjust her treatment plan accordingly.

Section 2

As the treatment regimen was initiated, the healthcare team closely monitored the patient's response to the interventions. Initially, the nebulized bronchodilator therapy appeared to provide some relief, as evidenced by a slight decrease in the use of accessory muscles. However, her respiratory rate remained elevated at 26 breaths per minute, and her oxygen saturation on supplemental oxygen improved marginally to 92%. Despite these changes, the patient reported persistent chest tightness and shortness of breath, raising concerns about the effectiveness of the current treatment plan.

During the subsequent assessment, the patient's vital signs revealed a heart rate of 110 beats per minute and a blood pressure of 148/88 mmHg, suggesting a sympathetic response to her respiratory distress. Further auscultation continued to show diffuse wheezing, with no significant improvement in the breath sounds at the lung bases. The healthcare team decided to repeat the peak expiratory flow rate (PEFR), which remained low at 210 L/min, indicating ongoing airflow limitation.

Recognizing the potential for complications such as status asthmaticus, the team opted to intensify the therapeutic approach. A continuous nebulization of bronchodilators was started, and the corticosteroid dosage was adjusted to ensure adequate anti-inflammatory effects. Additionally, a magnesium sulfate infusion was considered to further aid in bronchodilation. The patient was closely monitored for any signs of fatigue or respiratory failure, which could necessitate more aggressive interventions such as non-invasive ventilation or, in severe cases, intubation. The focus remained on stabilizing her condition while planning for a comprehensive review of her asthma management strategy to prevent future exacerbations.

Section 3

As the healthcare team continued to monitor the patient, they observed a concerning change in her status. Despite the intensified treatment regimen, the patient's respiratory distress worsened. Her respiratory rate increased to 32 breaths per minute, and she appeared increasingly anxious and fatigued. The oxygen saturation, despite supplemental oxygen, dropped to 88%, indicating a potential progression towards respiratory failure. The patient's heart rate spiked to 128 beats per minute, and her blood pressure elevated to 158/94 mmHg, further emphasizing the body's stress response.

A repeat arterial blood gas analysis was performed, revealing a pH of 7.32, PaCO2 of 52 mmHg, and PaO2 of 58 mmHg. These findings suggested the development of respiratory acidosis, likely due to hypoventilation and impaired gas exchange. Concurrently, laboratory results showed an elevated lactate level of 4.5 mmol/L, raising concerns about tissue hypoxia and metabolic stress. These diagnostic results indicated that the patient was not only struggling with airflow limitation but also potentially heading towards a more severe complication, such as status asthmaticus.

Given these developments, the healthcare team convened to reassess the management plan. The priority was to prevent further deterioration by considering non-invasive ventilation to support her breathing efforts and alleviate respiratory muscle fatigue. Additionally, the team revisited the patient's history and potential triggers, including recent exposure to allergens or non-compliance with maintenance therapy, to refine her long-term asthma management plan. These steps were crucial in stabilizing her acute condition and formulating a strategy to prevent future exacerbations, while closely monitoring for any signs that might necessitate intubation and mechanical ventilation.

Section 4

As the healthcare team implemented non-invasive ventilation, they closely monitored the patient's response to this intervention. Initially, there was a slight improvement in her respiratory status; her respiratory rate decreased to 28 breaths per minute, and her oxygen saturation improved to 92% with the continued use of high-flow oxygen. However, the patient remained visibly anxious, with shallow breathing and significant use of accessory muscles, indicating persistent respiratory effort. Her heart rate stabilized slightly at 120 beats per minute, though her blood pressure remained elevated at 154/92 mmHg.

Despite these initial improvements, subsequent arterial blood gas analysis showed minimal changes. The pH was 7.34, PaCO2 was 50 mmHg, and PaO2 remained low at 60 mmHg, suggesting ongoing respiratory acidosis and insufficient gas exchange improvement. The lactate level decreased marginally to 4.0 mmol/L, yet still indicated metabolic stress. Due to these mixed results, the team debated the next steps, weighing the risks and benefits of escalating to invasive mechanical ventilation if the patient's condition did not continue to improve.

During this critical decision-making period, the team explored potential underlying factors contributing to the patient's deteriorating status. A thorough review of her medication regimen revealed recent lapses in adherence to her maintenance inhalers, likely exacerbating her condition. Additionally, her family mentioned a recent increase in environmental triggers, such as exposure to construction dust at home. With this information, the team emphasized the importance of strict adherence to her asthma management plan and took steps to educate both the patient and her family about environmental control measures. These efforts aimed to stabilize her current condition and mitigate risks of future exacerbations, while remaining vigilant for any signs that might necessitate more aggressive interventions.

Section 5

As the team continued to monitor the patient's response to non-invasive ventilation, a change in her status became evident. Approximately two hours after the initial intervention, the patient began exhibiting signs of increased respiratory distress. Her respiratory rate began to climb again, reaching 34 breaths per minute, and her oxygen saturation dropped to 88% despite the continued use of high-flow oxygen therapy. She appeared more fatigued, and her use of accessory muscles became even more pronounced. Her heart rate also rose to 132 beats per minute, indicating increased cardiac workload, while her blood pressure remained elevated at 160/94 mmHg.

In light of these developments, the team ordered a repeat arterial blood gas analysis, which revealed a further decline in her respiratory status. The pH had decreased to 7.30, and PaCO2 had risen to 55 mmHg, indicating worsening respiratory acidosis. PaO2 continued to be compromised at 58 mmHg. The lactate level, although slightly reduced to 3.8 mmol/L, still pointed towards ongoing metabolic stress. These findings suggested that the patient's respiratory muscles might be tiring, raising concern for impending respiratory failure.

Given the deterioration in the patient's clinical status, the healthcare team convened to reassess the treatment plan. They considered the need for more aggressive interventions, such as transitioning to invasive mechanical ventilation, to prevent further decline and support her respiratory function. Simultaneously, they reinforced the importance of optimizing her asthma management by ensuring consistent use of her maintenance inhalers and addressing the environmental triggers at home. The team also initiated a consultation with the pulmonology specialist to explore potential adjustments to her long-term asthma management plan, aiming to prevent future exacerbations and improve her overall disease control.